Vimarsana
Biggest News Aggregation in the World

Page 42 - Benjamin Brafman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Benjamin Brafman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Benjamin Brafman Today - Breaking & Trending Today

The 2022 Law Power 100 - Vimarsana News

The 2022 Law Power 100

The legal minds influencing New York City and state politics.

Nancy Jo, This is ONTD Calling. I'm Calling to Let You Know How Satisfied I am With Your Stories - Vimarsana News

Nancy Jo, This is ONTD Calling. I'm Calling to Let You Know How Satisfied I am With Your Stories

Let's look back at 5 of of Nancy Jo Sales' OTHER stories for Vanity Fair that you may have missed or forgotten about. TWENTY NINE DOLLARS! EVERY TIME YOU FUCKING YELL I HAVE TO RE-TYPE IT!! Nancy Jo, this is ONTD calling. I am calling to let you know how much I enjoyed the following 5 stories:…

Blue Cross settles class action suit naming 'pharma bro' Martin Shkreli for $28M - Vimarsana News

Blue Cross settles class action suit naming 'pharma bro' Martin Shkreli for $28M

Shkreli controversially raised the price of the drug Daraprim, which is used to treat a potentially fatal parasitic infection, by 4,000%, from $13.50 to $750 per pill in 2015. In January, a federal judge banned him from the pharmaceutical industry for life.

Ghislaine Maxwell's Bid for a New Trial Faces a Major Hurdle - Vimarsana News

Ghislaine Maxwell's Bid for a New Trial Faces a Major Hurdle

The rule that a trial judge cannot ask what happened in the jury room could block an attempt by Ms. Maxwell’s lawyers to overturn the verdict.

'Pharma bro' Martin Shkreli ordered to pay $64m., banned from industry - Vimarsana News

'Pharma bro' Martin Shkreli ordered to pay $64m., banned from industry

The FTC and seven states, including New York, sued in January 2020 accusing Vyera Pharmaceuticals — formerly Shkreli’s company Turing — of increasing the price of Daraprim by more than 4,000%.

Source: jpost.com